To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED)
NCT00482196
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
173
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
MK0493
Sponsor
Merck Sharp & Dohme LLC